46,XY partial gonadal dysgenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251510OMIM:616067Q56.1
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

46,XY partial gonadal dysgenesis (also known as 46,XY PGD, partial testicular dysgenesis, or ambiguous genitalia due to partial gonadal dysgenesis) is a rare disorder of sex development (DSD) in which individuals have a 46,XY karyotype but their gonads (testes) do not develop fully. Unlike complete gonadal dysgenesis where the testes fail to form entirely, in partial gonadal dysgenesis there is some residual testicular tissue that produces variable amounts of testosterone and anti-Müllerian hormone (AMH). This results in ambiguous genitalia at birth, with features that may range from predominantly female to predominantly male external appearance, depending on the degree of testicular function during fetal development. The condition primarily affects the reproductive and endocrine systems. Key clinical features include ambiguous external genitalia (such as micropenis, hypospadias, bifid scrotum, or clitoromegaly), the possible presence of both Müllerian structures (such as a rudimentary uterus or fallopian tubes) and Wolffian duct derivatives, and dysgenetic gonads that may appear as streak gonads or partially formed testes. Cryptorchidism (undescended testes) is common. Individuals with this condition are at increased risk for gonadal tumors, particularly gonadoblastoma and dysgerminoma, especially if dysgenetic gonadal tissue is retained. Several genes have been implicated in 46,XY partial gonadal dysgenesis, including mutations in SRY, NR5A1 (SF1), DHH, MAP3K1, and other genes involved in testicular determination and differentiation. The inheritance pattern varies depending on the underlying genetic cause. Management is individualized and may include hormone replacement therapy (testosterone or estrogen depending on the sex of rearing), surgical correction of genital ambiguity, gonadectomy to reduce tumor risk in retained dysgenetic gonads, and psychological support. Sex assignment decisions are made collaboratively with families and a multidisciplinary team, taking into account the degree of virilization, potential for fertility, and psychosocial considerations.

Also known as:

Clinical phenotype terms— hover any for plain English:

Decreased serum estradiolHP:0008214Elevated circulating follicle stimulating hormone levelHP:0008232Clitoral hypertrophyHP:0008665Hypoplasia of the vaginaHP:0008726Female external genitalia in individual with 46,XY karyotypeHP:0008730Streak ovaryHP:0010464Elevated circulating luteinizing hormone levelHP:0011969Abnormal sex determinationHP:0012244Vanishing testisHP:0012870Decreased serum testosterone concentrationHP:0040171Urogenital sinus anomalyHP:0100779GonadoblastomaHP:0000150Testicular gonadoblastomaHP:0000030Ovarian gonadoblastomaHP:0000149Adrenal insufficiencyHP:0000846
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 46,XY partial gonadal dysgenesis.

View clinical trials →

No actively recruiting trials found for 46,XY partial gonadal dysgenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 46,XY partial gonadal dysgenesis community →

Specialists

1 foundView all specialists →
VM
Veronica Gomez-Lobo, M.D.
WASHINGTON, DC
Specialist
PI on 6 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 46,XY partial gonadal dysgenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 46,XY partial gonadal dysgenesisForum →

No community posts yet. Be the first to share your experience with 46,XY partial gonadal dysgenesis.

Start the conversation →

Latest news about 46,XY partial gonadal dysgenesis

No recent news articles for 46,XY partial gonadal dysgenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 46,XY partial gonadal dysgenesis

What is 46,XY partial gonadal dysgenesis?

46,XY partial gonadal dysgenesis (also known as 46,XY PGD, partial testicular dysgenesis, or ambiguous genitalia due to partial gonadal dysgenesis) is a rare disorder of sex development (DSD) in which individuals have a 46,XY karyotype but their gonads (testes) do not develop fully. Unlike complete gonadal dysgenesis where the testes fail to form entirely, in partial gonadal dysgenesis there is some residual testicular tissue that produces variable amounts of testosterone and anti-Müllerian hormone (AMH). This results in ambiguous genitalia at birth, with features that may range from predomina

At what age does 46,XY partial gonadal dysgenesis typically begin?

Typical onset of 46,XY partial gonadal dysgenesis is neonatal. Age of onset can vary across affected individuals.

Which specialists treat 46,XY partial gonadal dysgenesis?

1 specialists and care centers treating 46,XY partial gonadal dysgenesis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.